The health diagnostics sector includes all those companies dedicated to the development of techniques and instruments that facilitate the early diagnosis of pathologies and/or diseases and enable action to be taken against them as soon as possible.
Technological progress, the application of artificial intelligence in medicine and the rise of biotechnology have enabled strong growth in the sector. health diagnostics in recent years.
Since 2010, more than 1,500 companies have been created and around $13 billion in funding has been raised. Moreover, since 2018, growth has accelerated, raising almost $6 billion in some 300 funding rounds in just one year.
One of the most relevant operations of 2019 at the global level was that of Tangen Bioscienceswhich launched its second round (Round B) of fundraising for a total value of $75 million. Another important launch in 2019 was that of Zavathe medical and pharmaceutical services brand that raised $32 million in its first round (Round A). In addition, the company specialising in gut health Cara Care raised $26.4 million in its second round of funding.
The most active investors in the A and B rounds in health diagnostics were the Novartis Venture Funds, F-Prime Capital and the Singaporean investment company Temasek Holdings.
The most active investors in the A and B rounds in health diagnostics have been the funds Novartis Venture, F- Prime Capital and Singaporean investment company Temasek Holdings.
One of the acquisitions The most significant acquisition in recent years was that of Envision Healthcare by the well-known US investment firm Kohlberg Kravis Roberts (KKR) for $750 million in June 2018.
The pharmaceutical company Roche acquired in February 2018 Flatiron Healtha company dedicated to the research and development of cancer solutions.
The most important acquisition in 2019 was the acquisition of the pharmaceutical company Nightstar Therapeutics for Biogen. The deal was valued at $174.6 million.
EN 
ES